Natco Pharma Shares Drop 15 Following Weak Q4 Results Net Profit Falls 34 YoY PHAT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Steep Operating Costs SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms